BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15993425)

  • 1. Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system.
    Barnett-Norris J; Lynch D; Reggio PH
    Life Sci; 2005 Aug; 77(14):1625-39. PubMed ID: 15993425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide.
    McFarland MJ; Porter AC; Rakhshan FR; Rawat DS; Gibbs RA; Barker EL
    J Biol Chem; 2004 Oct; 279(40):41991-7. PubMed ID: 15292270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains.
    Patel HH; Murray F; Insel PA
    Handb Exp Pharmacol; 2008; (186):167-84. PubMed ID: 18491052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid rafts: a nexus for endocannabinoid signaling?
    McFarland MJ; Barker EL
    Life Sci; 2005 Aug; 77(14):1640-50. PubMed ID: 15978630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.
    Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?
    Chini B; Parenti M
    J Mol Endocrinol; 2004 Apr; 32(2):325-38. PubMed ID: 15072542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide.
    McFarland MJ; Terebova EA; Barker EL
    AAPS J; 2006 Mar; 8(1):E95-100. PubMed ID: 16584138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.
    McFarland MJ; Bardell TK; Yates ML; Placzek EA; Barker EL
    Mol Pharmacol; 2008 Jul; 74(1):101-8. PubMed ID: 18436710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lipid rafts/caveolae in the anticancer effect of endocannabinoids.
    Grimaldi C; Capasso A
    Mini Rev Med Chem; 2012 Oct; 12(11):1119-26. PubMed ID: 22625418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organized trafficking of anandamide and related lipids.
    Yates ML; Barker EL
    Vitam Horm; 2009; 81():25-53. PubMed ID: 19647107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the endocannabinoid system by lipid rafts.
    Dainese E; Oddi S; Bari M; Maccarrone M
    Curr Med Chem; 2007; 14(25):2702-15. PubMed ID: 17979719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and signaling of GPCRs in lipid rafts.
    Villar VA; Cuevas S; Zheng X; Jose PA
    Methods Cell Biol; 2016; 132():3-23. PubMed ID: 26928536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations of the endocannabinoid N-arachidonoylethanolamine (anandamide) in a phospholipid bilayer: probing structure and dynamics.
    Lynch DL; Reggio PH
    J Med Chem; 2005 Jul; 48(15):4824-33. PubMed ID: 16033262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
    Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid rafts and caveolae and their role in compartmentation of redox signaling.
    Patel HH; Insel PA
    Antioxid Redox Signal; 2009 Jun; 11(6):1357-72. PubMed ID: 19061440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good news for CB1 receptors: endogenous agonists are in the right place.
    Maccarrone M
    Br J Pharmacol; 2008 Jan; 153(2):179-81. PubMed ID: 17994111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterol carrier protein-2 selectively alters lipid composition and cholesterol dynamics of caveolae/lipid raft vs nonraft domains in L-cell fibroblast plasma membranes.
    Atshaves BP; Gallegos AM; McIntosh AL; Kier AB; Schroeder F
    Biochemistry; 2003 Dec; 42(49):14583-98. PubMed ID: 14661971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line.
    Rimmerman N; Hughes HV; Bradshaw HB; Pazos MX; Mackie K; Prieto AL; Walker JM
    Br J Pharmacol; 2008 Jan; 153(2):380-9. PubMed ID: 17965731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolae facilitate but are not essential for platelet-activating factor-mediated calcium mobilization and extracellular signal-regulated kinase activation.
    Poisson C; Rollin S; Véronneau S; Bousquet SM; Larrivée JF; Le Gouill C; Boulay G; Stankova J; Rola-Pleszczynski M
    J Immunol; 2009 Aug; 183(4):2747-57. PubMed ID: 19620302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.